Department of Otorhinolaryngology, Head and Neck Surgery, Medical Faculty of Mannheim, University of Heidelberg, Mannheim, Germany.
Anticancer Res. 2013 Jun;33(6):2457-65.
Head and neck squamous cell carcinoma (HNSCC) is the sixth most common type of cancer worldwide. In several tumour entities, the tyrosine kinase receptor c-KIT is associated with tumour transformation in the epithelial tissue in cases of aberrant expression. Furthermore, tumour development and dissemination are a result of dysregulated cellular pathways such as the WNT/β-catenin pathway. β-Catenin is a multifunctional protein within the canonical WNT signalling pathway and a pivotal factor for the stabilization of cell-cell interactions. In malignant tissues, β-catenin triggers tumour proliferation and progression. The aim of this study is to investigate the expression patterns of c-KIT and β-catenin in human papillomavirus-negative and p16-positive SCC and to evaluate the chemosensitivity of the tumour cells to the chemotherapeutical agents docetaxel and 5-fluorouracil (5-FU).
We incubated the tumour cell lines with docetaxel (5 μmol/ml) and 5-FU (1 μmol/ml) and detected β-catenin and c-KIT by immunohistochemistry and enzyme-linked immunosorbent assay (ELISA) after 48, 72, 120, 192 and 240 h.
We found a reliable trend towards decreased β-catenin expression levels in p16-positive and p16-negative tumour cell lines when incubated with docetaxel, in addition to induced apoptotic effect. At best, 5-FU had a slight influence on the alteration of the expression of β-catenin. Dose escalation of docetaxel and 5-FU had no statistically significant effect on the expression of β-catenin or c-KIT. In HPV-negative HNSCC, a reduced expression level of β-catenin and c-KIT was detected in an incubation period-dependent manner. p16-transformed SCC (CERV196) cells were characterized by a reduced susceptibility to docetaxel induced alteration of β-catenin expression.
We were unable to confirm the clinically-substantiated increased chemosensitivity of p16-positive tumour cells in vitro. Extended studies and clinical trials are needed to investigate these findings further in HPV-associated HNSCC.
头颈部鳞状细胞癌(HNSCC)是全球第六大常见癌症。在几种肿瘤实体中,酪氨酸激酶受体 c-KIT 在上皮组织中异常表达时与肿瘤转化有关。此外,肿瘤的发生和转移是细胞通路失调的结果,如 WNT/β-catenin 通路。β-catenin 是经典 WNT 信号通路中的一种多功能蛋白,是稳定细胞间相互作用的关键因素。在恶性组织中,β-catenin 触发肿瘤增殖和进展。本研究旨在探讨 c-KIT 和β-catenin 在人乳头瘤病毒阴性和 p16 阳性 SCC 中的表达模式,并评估肿瘤细胞对化疗药物多西紫杉醇和 5-氟尿嘧啶(5-FU)的化疗敏感性。
我们用多西紫杉醇(5μmol/ml)和 5-FU(1μmol/ml)孵育肿瘤细胞系,并在 48、72、120、192 和 240 h 后通过免疫组化和酶联免疫吸附试验(ELISA)检测β-catenin 和 c-KIT。
我们发现,在用多西紫杉醇孵育时,p16 阳性和 p16 阴性肿瘤细胞系的β-catenin 表达水平呈可靠下降趋势,此外还具有诱导凋亡作用。5-FU 对β-catenin 表达的改变影响最小。多西紫杉醇和 5-FU 的剂量递增对β-catenin 或 c-KIT 的表达没有统计学意义。在 HPV 阴性的 HNSCC 中,β-catenin 和 c-KIT 的表达水平呈孵育时间依赖性降低。p16 转化的 SCC(CERV196)细胞对多西紫杉醇诱导的β-catenin 表达改变的敏感性降低。
我们无法证实体外 p16 阳性肿瘤细胞的临床证实的化疗敏感性增加。需要进一步的研究和临床试验来进一步研究 HPV 相关 HNSCC 中的这些发现。